Literature DB >> 3462003

Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.

D Terziivanov, Z Gerova, V Vlahov, A Merdzhanov, D Damjanov.   

Abstract

Six patients, aged 52 to 71 years, with T-tube drainage of the common bile duct and a urinary catheter after cholecystectomy, were studied in order to evaluate the urinary and biliary excretion and pharmacokinetics of cefotiam in the early postoperative period. Each patient received cefotiam 1 g i.v. as a bolus injection. Cefotiam in plasma, urine, and bile were determined by HPLC. A 2-compartment open model with elimination from the central compartment satisfactorily fitted the plasma levels of the drug. The renal clearance of cefotiam (CLR = 133 ml/min) was an order of magnitude greater than its biliary clearance (CLB = 11.8 ml/min). Glomerular filtration was the main mechanism for elimination of cefotiam. The values of CLR and CLB in relation to the total plasma clearance (CL = 138. ml/min) demonstrated the negligible role of metabolism in elimination of cefotiam in these patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462003     DOI: 10.1007/BF00607957

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

2.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

3.  Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.

Authors:  B Kemmerich; H Lode; G Belmega; T Jendroschek; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

4.  Metabolic fate of SCE-963, a new broad-spectrum cephalosporin, after parenteral administration in rats and dogs.

Authors:  S Tanayama; T Kondo; Y Kanai
Journal:  J Antibiot (Tokyo)       Date:  1978-07       Impact factor: 2.649

5.  Pharmacokinetics of biliary excretion in man V. Dibromosulfophthalein.

Authors:  D K Meijer; J G Weitering; G A Vermeer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Comparative pharmacokinetics of d-tubocurarine and metocurine in man.

Authors:  D K Meijer; J G Weitering; G A Vermeer; A H Scaf
Journal:  Anesthesiology       Date:  1979-11       Impact factor: 7.892

7.  Systematic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography.

Authors:  M C Rouan; F Abadie; A Leclerc; F Juge
Journal:  J Chromatogr       Date:  1983-06-10
  7 in total
  1 in total

1.  Pharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacin.

Authors:  M Staneva; B Markova; I Atanasova; D Terziivanov
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.